ArticleBiomedical reports2026
Contribution of platelet-rich plasma to the surgical treatment of rotator cuff tear: An experimental study.
Article in Biomedical reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07689383 (The Contribution of Platelet-Rich Plasma to the Surgical Treatment of Rotator Cuff Tear), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Contribution of Platelet-Rich Plasma to the Surgical Treatment of Rotator Cuff Tear: An Experimental Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shoulder rotator cuff tears are a common condition, which under specific indications is treated with arthroscopic repair. The optimal treatment aims at alleviating shoulder pain, the return of shoulder functionality and the prevention of recurrence of symptoms. The aim of the present study was to investigate and describe the augmentation of arthroscopic repair of rotator cuff tears with platelet-rich-plasma (PRP) treatment postoperatively, and its effects on pain, shoulder functionality and risk of retear. A total of 51 patients were divided into two groups. The treatment group received a subacromial PRP injection in the direct postoperative period after arthroscopic repair of rotator cuff tears, while the control group underwent arthroscopic treatment alone. There was no statistically significant difference in the verbal numeric rating score at 30 days postoperatively and the Constant-Murley and American Shoulder and Elbow Surgeons shoulder scores at 3, 6 and 12 months postoperatively between the two groups. However, the patients in the treatment group exhibited a statistically significant improvement of both scores between the 3- and 6-month timepoints, which was not observed in the control group. A smaller portion of the treatment group had rotator cuff retears compared with the control group (42.86 vs. 75.00%), although this was not statistically significant. It has not yet been adequately established that PRP treatment can provide additional benefits when combined with surgical treatment of rotator cuff tears. Further research with larger sample sizes may provide sufficient data concerning a possible protective effect on the postoperative retear risk. The trial has been registered on ClinicalTrials.gov under number NCT07689383 (submission date, July 1, 2026) and can be accessed at: clinicaltrials.gov/study/NCT07689383?term=NCT07689383&viewType=Card&rank=1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.